Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 775 participants.
Also called NCT02921230
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 775 participants
- Sponsor
- Registry
-
NCT02921230
-
- Other papers using this trial's data
- Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Austria, Belgium, France, Germany, Ireland, Italy, Netherlands, Spain, Switzerland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02921230. Randomized; single masking; primary purpose treatment. Start 2016-10-25 (actual); primary completion 2021-07-02 (actual). Results posted on 2024-10-28.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery
- Acronym
- EMINENT
- Condition
- Arterial Occlusive Diseases
- Condition
- Atherosclerosis
- Condition
- Vascular Diseases
- Condition
- Arteriosclerosis
- Intervention (Device)
- Peripheral stenting
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct02921230- Content hash
b344887501f4535282d8adc431f7b9e98a68e8190d75e8f35f4417adf2ad62c9